MONIQUE GILBERT: Open Payments
NPI 1154729606 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 29 payments from 16 companies in 2025. Trend: 2023 $872 · 2024 $1,168 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $129 |
| Phathom Pharmaceuticals, Inc. | 1 | $88 |
| Novo Nordisk Inc | 3 | $60 |
| ABBVIE INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Eisai Inc. | 1 | $32 |
| Boston Scientific Corporation | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: BREZTRI, VOQUEZNA, UBRELVY, MOUNJARO, JARDIANCE, Leqembi, WATCHMAN FLX, LEQVIO.
Industry payments across FL — which companies pay providers there.
